VACCINE PURCHASE AND SALE AGREEMENTVaccine Purchase and Sale Agreement • May 2nd, 2006 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 2nd, 2006 Company Industry JurisdictionTHIS VACCINE PURCHASE AND SALE AGREEMENT (this “Agreement”) is made as of April 28, 2006 (the “Effective Date”) by and between Biovax, Inc., a Florida corporation with offices located at 377 Plantation St., Worcester, Massachusetts 01605 (“Biovax”) and Biovest International, Inc., a Delaware corporation, with its offices located at 324 S. Hyde Park Avenue Suite 350, Tampa, Florida 33606 (“Biovest” and with Biovax, the “Parties” or singularly a “Party”).
VACCINE PURCHASE AND SALE AGREEMENTVaccine Purchase and Sale Agreement • May 2nd, 2006 • Biovest International Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 2nd, 2006 Company Industry JurisdictionTHIS VACCINE PURCHASE AND SALE AGREEMENT (this “Agreement”) is made as of April 28, 2006 (the “Effective Date”) by and between Biovax, Inc., a Florida corporation with offices located at 377 Plantation St., Worcester, Massachusetts 01605 (“Biovax”) and Biovest International, Inc., a Delaware corporation, with its offices located at 324 S. Hyde Park Avenue Suite 350, Tampa, Florida 33606 (“Biovest” and with Biovax, the “Parties” or singularly a “Party”).